The cell cycle is the sequence of events a cell goes through to grow, replicate its DNA, and divide into two daughter cells. Each phase has specific tasks and built-in checkpoints that prevent the cell from moving forward until conditions are right. This regulation is essential for maintaining genomic stability, and when it breaks down, the result can be uncontrolled growth and cancer.
Cell Cycle Phases and Regulation
Phases of the cell cycle
The cell cycle has two major parts: interphase (where the cell spends most of its time growing and copying DNA) and the M phase (where the cell actually divides).
Interphase
- G1 phase (Gap 1): The cell grows in size and synthesizes proteins and organelles (ribosomes, mitochondria) in preparation for DNA replication. During G1, the cell also responds to external signals like growth factors and nutrient availability to determine whether conditions are suitable for division. If signals are unfavorable, the cell can exit the cycle and enter a quiescent state called G0.
- S phase (Synthesis): DNA replication occurs. Each chromosome is duplicated to produce two identical sister chromatids joined at the centromere. By the end of S phase, the cell has twice its original amount of DNA.
- G2 phase (Gap 2): The cell continues growing and synthesizes proteins needed for mitosis. Additional organelles (Golgi apparatus, endoplasmic reticulum) are produced. DNA repair mechanisms also scan for and correct replication errors before the cell commits to division.
Mitosis (M phase)
Mitosis is the division of the nucleus into two genetically identical nuclei. It proceeds through four stages:
- Prophase: Chromatin condenses into visible chromosomes. The nuclear envelope breaks down into vesicles. Centrosomes migrate to opposite poles of the cell and begin assembling the mitotic spindle.
- Metaphase: Chromosomes align along the cell's equatorial plane (the metaphase plate). Spindle fibers attach to the kinetochore on each sister chromatid, ensuring each chromatid is connected to opposite poles.
- Anaphase: Spindle fibers shorten, pulling sister chromatids apart toward opposite poles. By the end of anaphase, each pole has a complete set of chromosomes.
- Telophase and Cytokinesis: A nuclear envelope re-forms around each set of chromosomes, and the chromosomes decondense back into chromatin. Cytokinesis then divides the cytoplasm and organelles into two daughter cells. In animal cells this happens via a cleavage furrow (a contractile ring of actin pinches the cell in two), while in plant cells a cell plate forms between the two new nuclei.
Cyclins and CDKs in regulation
The cell cycle is driven forward by the activity of cyclin-dependent kinases (CDKs), which are enzymes that phosphorylate target proteins to trigger specific cell cycle events. CDKs are only active when bound to a partner protein called a cyclin.
- Cyclins are regulatory proteins whose concentrations rise and fall at specific points in the cell cycle. Different cyclins accumulate during different phases, then get degraded once their job is done.
- CDKs are serine/threonine kinases that are always present in the cell but remain inactive until a cyclin binds to them. The cyclin partner also determines which substrates the CDK will phosphorylate.
Specific cyclin-CDK complexes control each major transition:
| Complex | Phase Transition | Key Action |
|---|---|---|
| Cyclin D – CDK4/6 | Entry into and progression through G1 | Phosphorylates the retinoblastoma protein (Rb), releasing the E2F transcription factor to activate genes needed for S phase |
| Cyclin E – CDK2 | G1 → S transition | Phosphorylates proteins that initiate DNA replication |
| Cyclin A – CDK2 | S phase progression | Phosphorylates proteins involved in ongoing DNA replication and repair |
| Cyclin B – CDK1 | G2 → M transition | Phosphorylates proteins that trigger nuclear envelope breakdown and chromosome condensation |
The key concept here: the cell cycle isn't on autopilot. Each transition requires the right cyclin to accumulate, bind its CDK, and phosphorylate the correct targets before the cell moves forward.
Cell cycle checkpoints
Checkpoints are surveillance mechanisms that halt the cell cycle if something has gone wrong. Think of them as quality-control gates.
G1 checkpoint (Restriction Point)
This checkpoint verifies that the cell is large enough, has sufficient nutrients and growth factors, and has undamaged DNA before committing to S phase. The tumor suppressor p53 is central here. When DNA damage is detected, p53 activates transcription of p21, a CDK inhibitor that blocks cyclin-CDK activity and arrests the cell in G1. If the damage is irreparable, p53 can trigger apoptosis instead.
G2 checkpoint
Before entering mitosis, this checkpoint confirms that DNA replication is complete and free of errors. If DNA damage is detected, the checkpoint kinase Chk1 phosphorylates the phosphatase Cdc25, inactivating it. Since Cdc25 is needed to activate the Cyclin B–CDK1 complex, this effectively prevents entry into mitosis until repairs are made.
Spindle Assembly Checkpoint (SAC)
This checkpoint operates during metaphase. It prevents the transition to anaphase until every chromosome is properly attached to spindle fibers from both poles. Unattached kinetochores generate a "wait" signal through the proteins Mad2 and BubR1, which inhibit the anaphase-promoting complex/cyclosome (APC/C). The APC/C is the ubiquitin ligase that, once activated, tags securin for degradation, releasing the enzyme separase to cleave the cohesin holding sister chromatids together. Only when all kinetochores are properly attached does the SAC signal turn off and anaphase begin.
Why checkpoints matter: They prevent the propagation of mutations and chromosomal abnormalities to daughter cells, give repair machinery time to fix damage, and ensure each daughter cell receives a complete, accurate copy of the genome.
Dysregulation and cancer development
When cell cycle control mechanisms fail, cells can divide without restraint. This is a foundational step in cancer development.
How regulation breaks down:
- Oncogenes are mutated or overexpressed versions of normal genes (proto-oncogenes) that promote cell cycle progression. Gain-of-function mutations in cyclins, CDKs, or growth factor receptors can push cells through the cycle even without appropriate signals. For example, overexpression of the epidermal growth factor receptor (EGFR) is a common driver in lung cancer.
- Tumor suppressor genes normally act as brakes on the cell cycle. Loss-of-function mutations remove those brakes. The most frequently mutated tumor suppressor is p53, which is altered in over 50% of all human cancers. Other examples include Rb and p16.
Consequences of dysregulation:
- Accumulation of additional mutations and increasing genomic instability, since damaged cells keep dividing
- Evasion of apoptosis, allowing abnormal cells to survive rather than self-destruct
- Sustained proliferative signaling, meaning cells keep receiving "divide" signals even when they shouldn't
- Replicative immortality, where cells overcome normal senescence limits (often through reactivation of telomerase)
These are among the recognized hallmarks of cancer. Tumors develop as cells progressively acquire mutations in multiple cell cycle regulators. Because cancer so often depends on specific cyclin-CDK activity, targeting these complexes is an active area of therapy. CDK4/6 inhibitors (such as palbociclib) are already used in the treatment of hormone receptor-positive breast cancer, blocking the Cyclin D–CDK4/6 complex to prevent Rb phosphorylation and halt cell cycle entry.